UK markets closed

Aspira Women's Health Inc. (AWH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.3266+0.0466 (+1.42%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 41.06M
Enterprise value 41.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.36
Price/book (mrq)5.02
Enterprise value/revenue 4.51
Enterprise value/EBITDA -2.22

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-28.39%
S&P500 52-week change 322.36%
52-week high 36.7500
52-week low 32.3100
50-day moving average 33.6170
200-day moving average 33.9971

Share statistics

Avg vol (3-month) 323.88k
Avg vol (10-day) 38.99k
Shares outstanding 512.34M
Implied shares outstanding 612.8M
Float 89.36M
% held by insiders 138.84%
% held by institutions 19.09%
Shares short (15 Apr 2024) 4169.38k
Short ratio (15 Apr 2024) 45.37
Short % of float (15 Apr 2024) 41.89%
Short % of shares outstanding (15 Apr 2024) 41.37%
Shares short (prior month 15 Mar 2024) 4154.22k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 312 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -182.32%
Operating margin (ttm)-194.13%

Management effectiveness

Return on assets (ttm)-99.70%
Return on equity (ttm)-723.45%

Income statement

Revenue (ttm)9.15M
Revenue per share (ttm)0.99
Quarterly revenue growth (yoy)-1.10%
Gross profit (ttm)N/A
EBITDA -18.65M
Net income avi to common (ttm)-16.69M
Diluted EPS (ttm)-1.8100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.6M
Total cash per share (mrq)0.21
Total debt (mrq)2.85M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.03
Book value per share (mrq)-0.22

Cash flow statement

Operating cash flow (ttm)-15.89M
Levered free cash flow (ttm)-9.72M